There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > FGF basic

FGF basic

FGF basic Molecule Information

Name:Fibroblast growth factor 2
Target Synonym:FGF-2,Heparin-binding growth factor 2,Basic fibroblast growth factor,FGFB,bFGF,HBGF-2,FGF2,Fibroblast Growth Factor 2 (Basic),Basic Fibroblast Growth Factor BFGF,Prostatropin,Fibroblast Growth Factor 2
Number of Launched Drugs:3
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Approved

FGF basic Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
FGC-H81E3 Human Biotinylated Human FGF basic Protein, Avitag™,His Tag (MALS verified)
BFF-H4117 Human Human FGF basic Protein, Tag Free

FGF basic Part of Bioactivity data


Immobilized Human FGF basic, Tag Free (Cat. No. BFF-H4117) on CM5 Chip can bind Heparin with an affinity constant of 8.37 nM as determined in a SPR assay (Biacore T200) (Routinely tested).


Loaded Biotinylated Heparin on SA Biosensor, can bind Human FGF basic, Tag Free (Cat. No. BFF-H4117) with an affinity constant of 6.27 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

FGF basic Molecule Synonym Name


FGF basic Molecule Background

FGF basic is a member of the FGF family of at least 23 related mitogenic proteins which show 35-60% amino acid conservation. FGF acidic and basic, unlike the other members of the family, lack signal peptides and are apparently secreted by mechanisms other than the classical protein secretion pathway. FGF basic has been isolated from a number of sources, including neural tissue, pituitary, adrenal cortex, corpus luteum, and placenta. This factor contains four cysteine residues, but reduced FGF basic retains full biological activity, indicating that disulfide bonds are not required for this activity. bFGF is a critical component of human embryonic stem cell culture medium; the growth factor is necessary for the cells to remain in an undifferentiated state, although the mechanisms by which it does this are poorly defined. It has been demonstrated to induce gremlin expression which in turn is known to inhibit the induction of differentiation by bone morphogenetic proteins. It is necessary in mouse-feeder cell dependent culture systems, as well as in feeder and serum-free culture systems.

FGF basic References

FGF basic Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Thalidomide K-17; NSC-66847; NSC-527179 Approved Celgene Corp Thaled, Synovir, Talizer, Thalomid, Thalidomide Celgene, Thalidomide Pharmion Japan Leprosy, Lepromatous s:23:"Fujimoto Pharmaceutical"; 1982-01-01 HIV Infections; Spondylitis, Ankylosing; Myelodysplastic Syndromes; Multiple Myeloma; Erythema Nodosum; HIV Wasting Syndrome; Leprosy, Lepromatous; Carcinoma, Hepatocellular Details
Pentosan Polysulfate Sodium PPS; PZ-68; SP-54; AK-150 Approved Ivax, Teva Elmiron, Zilosul EU Cystitis, Interstitial s:22:"Bene-Arzneimittel Gmbh"; 1996-09-26 Pain; Cystitis, Interstitial; Prostatitis; Osteoarthritis, Knee Details

FGF basic Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
RBM-007 RBM-007; ID3 (21); APT-F2 Phase 2 Clinical Ribomic Macular Degeneration Details
Muparfostat sodium PI-88 Phase 3 Clinical Australian National University Liver Neoplasms; Solid tumours; Prostatic Neoplasms; Lung Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
Fibroblast growth factor 2 gene therapy (ID Pharma) SEV-10101; DVC-10101 Phase 2 Clinical Dnavec Ischemia; Peripheral Arterial Disease Details

This web search service is supported by Google Inc.